Overview Dividends

(XYL) Xylem - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US98419M1009

Pumps, Meters, Treatment, Analytics, Services

Industrial Machinery & Supplies & Components
Market Cap in USD: 33,499m

IPO / Inception: 2011-10-13
Return 12m vs S&P 500: 1.21%

EPS (Earnings per Share)

EPS CAGR: -37.34%
EPS Trend: 18.0%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: 15.46%
Rev. Trend: 92.9%

Last SUE: 0.87
Qual. Beats: 2

Dividends

Dividend Yield	1.17%
Yield on Cost 5y	1.70%
Yield CAGR 5y	9.33%
Payout Consistency	100.0%
Payout Ratio	33.1%

Risk via 5d forecast
Volatility	21.4%
Value at Risk 5%th	32.1%
Relative Tail Risk	-8.96%

Reward TTM
Sharpe Ratio	0.69
Alpha	4.15
CAGR/Max DD	0.30

Character TTM
Hurst Exponent	0.553
Beta	0.824
Beta Downside	0.870

Drawdowns 3y
Max DD	28.73%
Mean DD	9.00%
Median DD	8.97%

Description: XYL Xylem December 03, 2025

Xylem Inc. (NYSE:XYL) designs, manufactures, and services engineered water-related products for utility, industrial, residential, and commercial markets worldwide. The business is organized into four segments-Water Infrastructure; Applied Water; Measurement & Control Solutions; and Water Solutions & Services-offering a portfolio that spans pumps, treatment equipment, smart meters, data-analytics platforms, and managed maintenance services under brands such as Flygt, Sensus, and Bell & Gossett.

Key recent metrics: FY 2023 revenue reached roughly $5.6 billion, up 7 % YoY, with an adjusted operating margin of ~14 % and free cash flow of $850 million, supporting a 0.5 % dividend yield. The company’s growth is anchored to macro drivers including the U.S. $55 billion water-infrastructure funding bill, rising global water-scarcity concerns, and accelerating ESG capital allocation to resilient water-utility assets. Assuming continued capex rollout and stable demand for digital water-management services, Xylem’s 2024 guidance projects mid-single-digit revenue growth and incremental EPS expansion.

For a deeper quantitative view, you might explore Xylem’s metrics on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (948.0m TTM) > 0 and > 6% of Revenue (6% = 533.6m TTM)

FCFTA 0.05 (>2.0%) and ΔFCFTA 0.19pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 24.42% (prev 23.28%; Δ 1.14pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.07 (>3.0%) and CFO 1.27b > Net Income 948.0m (YES >=105%, WARN >=100%)

Net Debt (898.0m) to EBITDA (1.79b) ratio: 0.50 <= 3.0 (WARN <= 3.5)

Current Ratio 1.96 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (244.1m) change vs 12m ago 0.14% (target <= -2.0% for YES)

Gross Margin 38.23% (prev 36.97%; Δ 1.26pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 53.35% (prev 52.50%; Δ 0.85pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 38.12 (EBITDA TTM 1.79b / Interest Expense TTM 32.0m) >= 6 (WARN >= 3)

Altman Z'' 2.55

(A) 0.13 = (Total Current Assets 4.44b - Total Current Liabilities 2.27b) / Total Assets 17.30b

(B) 0.20 = Retained Earnings (Balance) 3.47b / Total Assets 17.30b

(D) 0.55 = Book Value of Equity 3.24b / Total Liabilities 5.85b

Total Rating: 2.55 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 67.14

1. Piotroski 6.50pt

2. FCF Yield 2.69%

3. FCF Margin 10.40%

4. Debt/Equity 0.19

5. Debt/Ebitda 0.50

6. ROIC - WACC (= -1.35)%

7. RoE 8.67%

8. Rev. Trend 92.92%

9. EPS Trend 18.03%

What is the price of XYL shares?

As of January 05, 2026, the stock is trading at USD 137.11 with a total of 671,587 shares traded.
Over the past week, the price has changed by -1.22%, over one month by -1.66%, over three months by -7.73% and over the past year by +19.66%.

Is XYL a buy, sell or hold?

Xylem has received a consensus analysts rating of 4.05. Therefore, it is recommended to buy XYL.

Strong Buy: 9
Buy: 5
Hold: 8
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the XYL price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	167.4	22.1%
Analysts Target Price	167.4	22.1%
ValueRay Target Price	141	2.8%

XYL Fundamental Data Overview January 01, 2026

Market Cap USD = 33.50b (33.50b USD * 1.0 USD.USD)
P/E Trailing = 35.4613
P/E Forward = 25.0627
P/S = 3.7665
P/B = 3.0069
P/EG = 2.1141
Beta = 1.174
Revenue TTM = 8.89b USD
EBIT TTM = 1.22b USD
EBITDA TTM = 1.79b USD
Long Term Debt = 1.91b USD (from longTermDebt, last quarter)
Short Term Debt = 176.0m USD (from shortTermDebt, last quarter)
Debt = 2.09b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 898.0m USD (from netDebt column, last quarter)
Enterprise Value = 34.40b USD (33.50b + Debt 2.09b - CCE 1.19b)
Interest Coverage Ratio = 38.12 (Ebit TTM 1.22b / Interest Expense TTM 32.0m)
FCF Yield = 2.69% (FCF TTM 925.0m / Enterprise Value 34.40b)
FCF Margin = 10.40% (FCF TTM 925.0m / Revenue TTM 8.89b)
Net Margin = 10.66% (Net Income TTM 948.0m / Revenue TTM 8.89b)
Gross Margin = 38.23% ((Revenue TTM 8.89b - Cost of Revenue TTM 5.49b) / Revenue TTM)
Gross Margin QoQ = 38.93% (prev 38.77%)
Tobins Q-Ratio = 1.99 (Enterprise Value 34.40b / Total Assets 17.30b)
Interest Expense / Debt = 0.29% (Interest Expense 6.00m / Debt 2.09b)
Taxrate = 23.91% (71.0m / 297.0m)
NOPAT = 928.4m (EBIT 1.22b * (1 - 23.91%))
Current Ratio = 1.96 (Total Current Assets 4.44b / Total Current Liabilities 2.27b)
Debt / Equity = 0.19 (Debt 2.09b / totalStockholderEquity, last quarter 11.21b)
Debt / EBITDA = 0.50 (Net Debt 898.0m / EBITDA 1.79b)
Debt / FCF = 0.97 (Net Debt 898.0m / FCF TTM 925.0m)
Total Stockholder Equity = 10.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.48% (Net Income 948.0m / Total Assets 17.30b)
RoE = 8.67% (Net Income TTM 948.0m / Total Stockholder Equity 10.93b)
RoCE = 9.50% (EBIT 1.22b / Capital Employed (Equity 10.93b + L.T.Debt 1.91b))
RoIC = 7.18% (NOPAT 928.4m / Invested Capital 12.93b)
WACC = 8.53% (E(33.50b)/V(35.59b) * Re(9.05%) + D(2.09b)/V(35.59b) * Rd(0.29%) * (1-Tc(0.24)))
Discount Rate = 9.05% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.54%
[DCF Debug] Terminal Value 78.24% ; FCFE base≈886.2m ; Y1≈1.09b ; Y5≈1.87b
Fair Price DCF = 108.1 (DCF Value 26.32b / Shares Outstanding 243.5m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 18.03 | EPS CAGR: -37.34% | SUE: -4.0 | # QB: 0
Revenue Correlation: 92.92 | Revenue CAGR: 15.46% | SUE: 0.87 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.16 | Chg30d=-0.000 | Revisions Net=+0 | Analysts=14
EPS next Year (2026-12-31): EPS=5.56 | Chg30d=+0.007 | Revisions Net=+0 | Growth EPS=+9.9% | Growth Revenue=+3.5%

Additional Sources for XYL Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle